N.J. High Court Mulls Vioxx Class Status; $30B At Stake
By Catherine Fredenburgh · July 24, 2006, 12:00 AM EDT
In a decision that dramatically raises the stakes for Merck & Co., New Jersey's State Supreme Court has agreed to hear the drug maker's appeal of the class certification of a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login